Lymphoma is a kind of blood cancer which occurs when B or T lymphocytes and leukocytes grow abnormally. In addition, it also occurs if these cells survive longer than their normal life cycle. Lymphoma generally occurs in lymph nodes, bone marrow, spleen, blood and other organs which form a part of the lymphatic system. The common symptoms of lymphoma are swelling of lymph nodes, fever, weight loss, night sweets, anorexia, itching, dyspnoea and fatigue. The common tests applied for the diagnosis of lymphoma are immunophenotyping, FISH (Fluorescence in Situ Hybridization) testing and flow cytometry. The most common method to threat lymphoma is chemotherapy.
Browse for full report: http://www.transparencymarketresearch.com/lymphoma-treatment-drugs.html
Since chemotherapy destroys the cancer cell by obstructing its division process, it acts as one of the key method for lymphoma treatment. These medicines travels throughout the body while medication. Various drugs are used for the treatment of lymphoma such as Adcertis (brentuximab), Arranon (nelarabine), Adriamycin (doxorubicin), Decadron (dexamethasone), Baycadron (dexamethasone), Deltasone (prednisone), Dexamethasone Intensol (dexamethasone), Dexpak Taperpak (dexamethasone) and Folotyn (pralatrexate). Other drugs used include Prednicot (prednisone), Roferon-A (interferon alfa-2a), Solurex (dexamethasone), Leukeran (chlorambucil), Zema Pak (dexamethasone), Velcade (bortezomib), Sterapred DS (prednisone), Thioplex (thiotepa), Velban (vinblastine) and Trexall (methotrexate).
Rise in the incidence of lymphoma throughout the globe would boost the growth of lymphoma treatment drugs market. According to Leukemia and Lymphoma Society, in 2012, around 700,000 people were suffering from lymphoma in Canada alone. The government of various nations such as U.S. and Europe has amplified their funding for R&D on lymphoma treating drugs which would further augment the growth of this market. Moreover, they have started many programs for patient awareness about lymphoma and its treatments. Despite all these advantages, various side effects of chemotherapy would hamper the growth of this market. These side effects include hair loss, nausea, vomiting and fatigue. In addition, high cost of this treatment would also hamper the growth of this market. Moreover, few nations such as U.K are not providing reimbursement for every lymphoma treating drug which would hamper its growth in this region. Some of the major players in lymphoma treatment drugs market includes Abbott Laboratories, Eli Lilly, Bristol-Myers Squibb, Abiogen, Johnson & Johnson, Aeterna Zentaris among others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
All new upcoming reports: http://www.transparencymarketresearch.com/latest.php?type=U
Browse another Blog: http://marketingresearchfirm.wordpress.com/
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report:
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments.
No comments:
Post a Comment